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Background: Gene expression profiling in pancreatic cancer is
complicated by the high amount of RNAses in human tissue
and suitable models. In order to reflect early metastasizing, mod-
els should be constructed with respect to the anatomical environ-
ment. Using the orthotopic pancreatic tumor SCID mouse model
these interactions are taken into account. In order to identify
genes associated with local tumor invasion and metastases in
ductal pancreatic cancer we investigated pancreatic tumor cell
lines derived from an orthotopic pancreatic tumor model in SCID
mice. Differential gene expression was performed based on cDNA
microarray technique.
Methods: Human MiaPaca cell lines were orthotopically
implanted in SCID mice (n = 18). Transcriptional profiling (Affyme-
trix, HGU133) was performed with tissue derived from the primary
tumor, duodenal tumor invasion frontier, and liver metastases.
Differentially expressed genes were identified after statistical
analysis (ANOVA) and validated with external data bases (NCBI:
PubMed, LokuslLink, Unigene, Swissprot, Geneontology).
Results: Of 22283 genes investigated, 1066 were high significantly
altered (p < 106). With respect to the primary tumor, in liver metas-
tases 196 genes were differentially expressed, whereas in the duo-
denal tumor invasion frontier 964 genes were altered. Comparing
current data bases we established a panel of 14 genes associated
with liver metastases and local invasion for functional validation.
These genes can be assigned to apoptosis (e.g. BNIP3L, GADD45A),
angiogenesis (VEGF), or cell migration and -adhesion (SERPINE1).
Conclusion: The SCID mouse model is able to simulate the
human metastasizing cascade in vivo and facilitate gene expres-
sion analyses. Using transcriptional profiling in the SCID mouse
model marker genes for local invasion and liver metastases can
be identified. These marker genes are associated with apoptosis,
angiogenesis, and cell interactions.
doi:10.1016/j.ejcsup.2006.04.125
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ROLE IN PANCREATIC CANCER CELL INVASIVENESS IN VITRO
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Background: Thrombosis and activation of coagulation are fre-
quently observed in cancer patients. This phenomenon is
reflected in the excess production of thrombin, which is thoughtto play an important role in the progression of different solid
tumors. Cellular effects of thrombin are mediated by the throm-
bin receptor PAR-1, a member of the G-protein coupled receptor
family. Aim of this study was to investigate the role of PAR-1 on
pancreatic cancer cell invasion.
Material and Methods: The human pancreatic cancer cell line
MIA PaCa-2, which expresses high levels of PAR-1, was transfec-
ted with an antisense construct against PAR-1. The expression
level of PAR-1 after transfection was determined by RT-PCR and
Western blot analysis. For invasion assays the respective trans-
fected, control transfected (sense and mock) and untransfected
cells were stimulated with thrombin (1.0 U/ml) and subjected to
a standardized Matrigel invasion assay. After 24 h the number
of invasive cells were counted.
Results: Antisense transfection resulted in 80% downregulation
of PAR-1 expression compared to parental MIA PaCa-2. In the
Matrigel invasion assay the number of invasive cells was signifi-
cantly reduced for the antisense transfected cells. The control
transfected cells showed no change of invasiveness compared
to untransfected MIA PaCa-2.
Conclusion: The expression of the thrombin receptor PAR-1 was
successfully reduced in pancreatic cancer cells by antisense
transfection. Downregulation of the thrombin receptor lead to
significantly reduced invasiveness in vitro. These results empha-
size the crucial role of PAR-1 in pancreatic cancer progression
in vitro. In vivo assays to confirm the impact of PAR-1 expression
on pancreatic cancer cell invasiveness are prospected.
doi:10.1016/j.ejcsup.2006.04.126
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Marian Gradea, Torsten Lierscha, Sudhir Varmac, Michael J.
Difilippantoniob, Claus Langera, Richard Simonc, Thomas Riedb,
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Background: There is a wide spectrum of tumor responsiveness of
rectal adenocarcinomas to preoperative chemoradiotherapy (CT/
RT) ranging from complete response to resistance. We therefore
investigated whether gene expression profiling can assist in strati-
fying patients into responders or non-responders. Furthermore, we
evaluated whether distinct gene expression signatures can be used
for individualized prognostication (disease free survival).
Methods: Pretherapeutic biopsies from 30 locally advanced rectal
carcinomas were analyzed using microarrays. Class comparison
was used to identify a set of genes that were differentially expressed
between responders and non-responders (as measured by T-level
down-sizing). Leave-one-out cross-validation (LOOCV) was per-
formed to explore the predictive value of the identified gene-set.
Results: Responders and non-responders showed significantly
different expression levels for 54 genes (p < 0.001). When we
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behavior (T-level down-sizing) in 83% of patients (p = 0.02). We
then observed that after a median follow-up of 34.5 months, all
five patients with metastatic disease belonged to the group of
non-responders. We again applied LOOCV and correctly predicted
all five patients with recurrence. Furthermore, all 11 patients who
were predicted to remain cancer free showed no evidence of
recurrence.
Conclusion: Our results suggest that pretherapeutical gene
expression profiling may assist in response prediction of rectal
adenocarcinomas to preoperative CT/RT and in prediction of dis-
ease free survival if validated in larger independent studies.
doi:10.1016/j.ejcsup.2006.04.127
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Background: Colorectal carcinomas develop through the
sequential stages of increasing morphological and molecular
alterations. While the correlation of tumor phenotype with asso-
ciated genomic alterations has been firmly established, the corre-
lation with global gene expression profiles is less.
Methods: We analyzed tissue samples from 36 patients to iden-
tify sequential alterations of the genome and transcriptome that
define the transformation of normal epithelium and the progres-
sion from adenomas to invasive disease.
Results: Comparative genomic hybridization (CGH) revealed pat-
terns of stage specific, recurrent genomic imbalances. Gene
expression analysis on 9K cDNA arrays identified 58 genes to be
differentially expressed between normal mucosa and adenoma,
116 genes between adenoma and carcinoma, and 158 genes
between primary carcinoma and liver metastasis (p < 0.001). Our
analysis revealed a direct correlation of chromosomal copy num-
ber changes with chromosome-specific average gene expression
levels.
Conclusion: Increasing genomic instability, a recurrent pattern
of chromosomal aberrations and a specific gene expression pat-
tern correlate with distinct stages of colorectal cancer progres-
sion. Chromosomal aneuploidies exert a direct effect on average
expression levels of the genes residing on the aneuploid chromo-
somes, thereby contributing to a massive deregulation of the cel-
lular transcriptome. The identification of novel genes and
proteins might deliver relevant molecular targets for diagnostic
and therapeutic interventions.
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Background: Antibodies against the human nuclear antigen pKi-
67 (Ki-67, MIB-1) are routinely used in oncology as immune-histo-
logical proliferation marker. PKi-67 is exclusively expressed in all
active phases of the cell cycle (G1,S, G2, Mitosis). The Ki-67 index
(relative number of positive stained nuclei) serves as an indepen-
dent prognostic marker for certain tumor entities. We investigated
whether colorectal cancer patients express auto-antibodies
against pKi-67 and whether this has a prognostic relevance.
Methods: Auto-antibodies were detected by Western blot stain-
ings from SW480 nuclear extracts with 36 pre- and 65 post-oper-
ative sera of colorectal cancer patients’ sera. Sera of 20 voluntary
healthy donors served as negative control. The same samples
were simultaneously tested for p53 auto-antibodies.
Results: Thirteen percent of the sera proved to be positive for
pKi-67 auto-antibodies while the control sera were completely
negative. p53 auto-antibodies could be found in 53% of the patient
sera. 75% anti-pKi-67 positive samples were also anti-p53 posi-
tive. For both antigens we found less positive antibodies in
post-operative sera (pKi-67: 9%; p53: 42%) than in pre-operative
sera (pKi-67: 19%, p53: 61%). There was, however, no significant
correlation between pKi-67 positive sera and tumor stage (I:
13%, II: 4%; III: 23%; IV: 13%), grading or patient’s prognosis.
Remarkably, there is a significant (p = 0,023) correlation of pKi-
67 positive sera of colon cancer patients (77%) in comparison to
rectal cancer patients (60%).
Conclusion: PKi-67 auto-antibodies could be diagnostically valu-
able in the early detection of neoplasia and could be used as
potential markers for recurrent or metastatic disease.
doi:10.1016/j.ejcsup.2006.04.129
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Purpose: Prognostic studies on transcription factors acting at
specific promoter elements have never been performed so far.
In previous studies we showed that the invasion-related gene u-
PAR is regulated especially via an AP-2/Sp1(-152/-135)-, and an
AP-1-promoter motif(-190/-171), mediating u-PAR-induction by
